Skip to main content

Table 2 Direct costs (US$) per hypertensive inpatient by disease classification and cost category

From: Direct costs of hypertensive patients admitted to hospital in Vietnam’ a bottom-up micro-costing analysis

Cost category

Median (and IQR) of costs

Mean (± SD) of costs

% of total costs of all patients

% of total costs of I10 group

% of total costs of I10 combine E75

All patients (n = 230)

I10 group (n = 147)

I10 combined E75 group (n = 83)

All patients (n = 230)

I10 group (n = 147)

I10 combined E75 group (n = 83)

Inpatient days

29.94 (14.97 - 39.92)

24.95 (9.98 - 34.93)

34.93 (24.95 - 44.91)

29.05 (±16.45)

24.86 (±15.94)

36.48 (±14.69)

41.37

40.01

43.14

Drugs

11.67 (4.63 - 39.76)

8.26 (3.69 - 37.02)

16.13 (8.47 - 51.47)

23.85 (±25.4)

21.24 (±25.26)

28.45 (±25.12)

33.96

34.19

33.65

Tests

13.00 (6.89 - 19.24)

11.56 (5.62 - 15.76)

13.69 (7.81 - 25.76)

15.84 (±13.88)

14.49 (±13.46)

18.22 (±14.37)

22.55

23.33

21.54

Others

1.23 (0.84 - 1.68)

1.17 (0.82 - 1.56)

1.41 (0.85 - 1.83)

1.49 (±2.26)

1.53 (±2.79)

1.41 (±0.6)

2.12

2.47

1.67

Total costs

64.95 (37.18 - 95.32)

53.41 (29.71 - 82.82)

77.64 (56.61 ±106.5)

70.23 (±42.89)

62.13 (±43.76)

84.56 (±37.46)

100

100

100